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Objective: Although intramural hematoma of the aorta is considered a unique
pathologic entity, the management of intramural hematoma involving the ascending
aorta (type A) has not been well established. The purpose of this study was to
establish the optimal mode of management of type A intramural hematoma.
Methods: We treated patients with type A intramural hematoma as follows. Early
operation was carried out only for patients with cardiac tamponade, impending
rupture, or rupture. Other patients were treated medically, but patients with pro-
gression of intramural hematoma during medical follow-up had their treatment
converted to surgery. From February 1992 to March 2001, a total of 33 patients with
type A intramural hematoma were treated as described here. Patients were divided
according to initial treatment into an early surgery group (n  9) and a medical
treatment group (n  24). Clinical profiles and in-hospital and long-term survival
rates were compared between the groups.
Results: Compared with the early surgery group, the medical treatment group was
younger (64.2 7.0 years vs 71.7 8.5 years, P .0319) and had a greater number
of involved segments (3.6  0.6 vs 3.0  0.9, P  .0395). Eight patients in the
medical treatment group were switched to surgery during follow-up because of
progression of intramural hematoma. In-hospital mortality rates in the early surgery
and medical groups were 11% and 5% (P  .477), respectively. Cumulative 1- and
2-year survivals were 89% and 89%, respectively, in the early surgery group, and
92% and 81%, respectively, in the medical group (P  .49).
Conclusion: We concluded that about 70% of type A intramural hematomas could
be managed expectantly, and more than 50% could be treated medically alone.
Intramural hematoma of the aorta (IMH) was first described in 1920 byKrukenberg and colleagues1 as “dissection without intimal tear.” CurrentlyIMH, the clinical presentations of which are similar to those of aorticdissection, is considered a unique pathologic entity.2-8 IMH is classified aseither involving (type A) or not involving (type B) the ascending aorta.Patients with type B IMH, like those with type B aortic dissection, are
usually treated medically.7 However, management of patients with type A IMH is
controversial. Some reports have recommended early surgery for patients with type
A IMH because of their poor prognosis with medical treatment.3-7 On the other
hand, cases of regression of type A IMH without surgical repair have also been
reported.8-10 Because of the pathophysiologic process involved in IMH, absence of
flow and pressure communication with the aortic lumen may produce good results.20
Since 1992, we have treated patients with type A IMH as follows. Early operation
is carried out only for patients with cardiac tamponade, impending rupture, or
rupture. Patients without tamponade or rupture are treated medically; however,
patients with recurrent pain, progression to overt type A dissection, or progressive
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aortic dilatation during medical follow-up have their treat-
ment converted to surgery. The purpose of this study was to
evaluate whether our management scheme was reasonable
and to attempt to establish the optimal mode of management
for type A IMH.
Patients and Methods
From February 1992 to March 2001, a total of 35 patients were
referred to our hospital with the diagnosis of type A IMH. The
diagnostic criteria for type A IMH were as follows: (1) symptoms
such as severe chest or back pain, such as in acute aortic dissec-
tion, (2) initial computed tomographic (CT) examination per-
formed within 24 hours from the onset of symptoms showing the
characteristic findings described by Yamada and associates12 (dis-
placed intimal calcification, increased external aortic diameter, a
crescent high-attenuation area along the aortic wall on plain CT
scan, a continuous spiral course of nonopacified soft tissue in the
aortic wall on contrast enhanced CT scan, and no evidence of
aortic intimal ulceration, disruption, or flap), and (3) involvement
of the ascending aorta. The diagnosis of IMH was confirmed by
operative findings showing the presence of thrombus or clot in the
wall of the ascending aorta and absence of intimal tear from the
ascending aorta to distal aortic arch or by serial CT findings
showing a morphologic change in aortic wall thickness.
Management of Type A IMH
Initial management of patients with type A IMH was based on
hemodynamic stability and clinical symptoms. Patients with he-
modynamic instability or persistent pain (with cardiac tamponade,
impending rupture, or rupture) underwent early surgery on an
emergency basis. Other patients were treated medically with in-
tensive antihypertensive therapy in the intensive care unit for a few
days. Blood pressure in these patients was monitored with an
arterial line, and calcium-channel antagonists, nitrates, or -adren-
ergic receptor blockers were administered intravenously to main-
tain systolic blood pressure between 100 and 130 mm Hg. Patients
were then transferred to the high-care unit, where they rested in
bed for 2 weeks. Angiotensin-converting enzyme inhibitors, cal-
cium-channel antagonists, and - or -adrenergic receptor block-
ers were administered orally to maintain blood pressure between
100 and 140 mm Hg. These patients remained in the hospital
another 2 weeks and were followed up as outpatients as they
resumed their previous lifestyle. During the medical treatment,
patients with recurrent pain, progression to overt type A dissection,
or progressive aortic dilatation of more than 60 mm had their
therapy converted to surgery. Two patients were excluded from
surgery, an 88-year-old woman with cardiac tamponade and a
75-year-old man in whom IMH had progressed to overt type A
dissection. Both were excluded from this study because they did
not conform to our protocol.
Computed Tomographic Examinations
CT images were obtained at 3- to 10-mm intervals from the aortic
arch to the aortic bifurcation, with and without contrast medium.
Initial CT scans were performed within 24 hours from the onset of
episode in all cases. Serial CT examinations were performed at 2
and 4 weeks after admission and at 3, 6, and 12 months after
discharge for medically treated patients. The maximum external
diameter and wall thickness of the ascending aorta were measured
at the level of the right pulmonary artery in the enhanced CT
images (Figure 1). The extent of IMH was expressed in numbers
of involved segments: involvement of the ascending aorta alone
was 1, that of the ascending aorta and the arch was 2, that from the
ascending to the descending aorta was 3, and that from the as-
cending to the abdominal aorta was 4.
In all but 1 case, follow-up was performed at least once a year
by direct or telephone contact or by communication with the
primary physician. The follow-up period ranged from 3 months to
114 months (mean 32.5  30.0 months).
Of the original 35 patients, 33 were included in this study. On
the basis of the initial treatment (within 24 hours after admission),
patients were divided into two groups, an early surgery group and
a medical treatment group. Clinical profiles and in-hospital and
long-term survivals were compared between the groups. For pa-
tients in the medical treatment group, clinical characteristics and
CT images were analyzed to identify predictors of change from
medical treatment to surgery.
Statistical Analysis
A software package (StatView 5.0 for Macintosh; SAS Institute,
Inc, Cary, NC) was used for statistical analysis. Continuous data
are presented as mean  SD, and categoric data are given as
patient numbers and percentages. Continuous variables were eval-
uated with the Mann-Whitney U test. Discrete variables were
treated by means of contingency table and analyzed with the Fisher
exact test. The 1- and 2-year survivals were estimated by the
Kaplan-Meier method and compared with log-rank tests. The Cox
proportional hazards model was used to identify the predictors of
change from medical treatment to surgery throughout the entire
follow-up period with the use of univariate and forward stepwise
Cox regression analysis (entry and removal thresholds of .05 and
.1, respectively).
Figure 1. Measurement of aortic dimensions. Maximum external
diameter is indicated by a and wall thickness from intima to
adventitia is indicated by b.
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Results
Nine of 33 patients (27%) underwent surgery on an emer-
gency basis within 24 hours after admission and were in-
cluded in the early surgery group. Five of 9 patients had
been in shock on admission because of cardiac tamponade
(n  3) or aortic rupture (n  2). Four patients had dete-
rioration in condition after admission because of cardiac
tamponade. Total arch replacement was performed in 3
patients, 2 with aortic rupture and 1 with cardiac tamponade
associated with distal aortic arch aneurysm. Replacement of
the ascending aorta was performed in 6 patients with cardiac
tamponade. One of the 7 patients with cardiac tamponade
required open drainage in the intensive care unit before
surgery.
Twenty-four of 33 patients (73%) were initially treated
medically and included in the medical treatment group.
Three patients had a history of type B IMH. Eleven patients
in this group had high blood pressure (160 mm Hg) on
admission. To maintain blood pressure at an appropriate
level, 3 of these 11 patients required mechanical ventilation
to put them under sedation.
Eight of 24 patients in the medical treatment group had
conversion of their treatment to surgery during the fol-
low-up period. Five of these 8 patients underwent surgery
during the same hospitalization. One patient reported recur-
rent severe back pain 3 weeks after admission and had
impending rupture diagnosed. Total arch replacement was
done in this patient on an emergency basis. In 4 cases, IMH
progressed to overt type A aortic dissection, which was
discovered by serial CT scan performed 4 weeks after
admission in the absence of any symptoms. Elective re-
placement of the ascending aorta was done in 3 cases and
elective total arch replacement with aortic valve replace-
ment was done in 1 case. In 2 patients, although IMH had
disappeared at the time of discharge, overt type A aortic
dissection was detected by serial CT scan performed 3
months after discharge. One patient underwent replacement
of the ascending aorta, and the other underwent simulta-
neous ascending and descending aorta replacement because
of association with progressive descending aortic dilatation.
Another patient underwent total arch replacement 4 years
after the initial episode of IMH with progressive aortic arch
dilatation. The interval between the onset of IMH and
conversion to surgery ranged from 24 days to 46 months.
The remaining 16 of 24 patients in the medical treatment
group were treated only medically. The IMH of these 16
patients had completely regressed by 1 year after discharge,
as confirmed by serial CT scans.
Table 1 presents comparisons of clinical characteristics
and CT findings between the early surgery group and med-
ical treatment group. The medical treatment group was
younger than the early surgery group (64.2  7.0 years vs
71.7  8.5 years, P  .0319). There were no statistically
significant differences between the groups in terms of sex,
hypertension, diabetes mellitus, hyperlipidemia, association
of cerebrovascular disease, cardiac disease, lung disease,
liver disease, renal dysfunction, abdominal aortic aneurysm,
and history of type B IMH.
The extent of IMH was significantly greater in the med-
ical treatment group than in the early surgery group (3.6 
0.6 vs 3.0  0.9, P  .0395). The maximum diameter and
wall thickness of the ascending aorta were not significantly
different between two groups.
One patient in the early surgery group died after the
operation. Although there were no IMH-related deaths in
the medical treatment group, 1 patient died of sepsis result-
ing from an associated complication, liver abscess. In-hos-
pital mortality rates in the early surgery group and the
medical treatment group were 11% and 4%, respectively
(P  .4773).
One patient in the early surgery group died of cerebral
bleeding 59 months after surgery. Three patients in the
medical treatment group died during the follow-up period:
the first died of chronic renal failure 7 months later, the
second died suddenly 18 months later and no autopsy was
TABLE 1. Comparisons of the clinical characteristics and
CT findings between the early surgery group and the med-
ical treatment group
Early surgery
(n  9)
Medical
treatment
(n  24)
P
value
Age (y) 71.7 8.5 64.2 7.0 .032
Sex ratio (male/female) 5:4 14:10 .999
Systolic blood pressure
on admission
Over 160 mm Hg 1 (11%) 11 (46%) .107
Below 90 mm Hg 5 (56%) 0 (0%) .001
Risk factors
Hypertension 8 (89%) 22 (92%) .999
Diabetes mellitus 0 (0%) 1 (4%) .999
Hyperlipidemia 0 (0%) 2 (8%) .999
History/associated
disorders
Cerebrovascular
disease
1 (11%) 6 (25%) .642
Cardiac disease 1 (11%) 6 (25%) .642
Lung disease 1 (11%) 1 (4%) .477
Liver disease 1 (11%) 6 (25%) .642
Renal dysfunction 1 (11%) 4 (17%) .999
Previous IMH 0 (0%) 3 (13%) .545
Abdominal aortic
aneurysm
0 (0%) 4 (17%) .555
CT examinations on
admission
Extent of IMH 3.0 0.9 3.6 0.6 .040
External diameter (mm) 47.4 5.1 46.0 6.6 .527
Wall thickness (mm) 12.1 8.7 0.6 4.7 .758
Hospital death 1 (11%) 1 (4%) .477
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performed, and the third died of lung cancer 21 months
later. The overall cumulative 1- and 2-year survivals were
89% and 89% in the early surgery group and 91% and 81%
in the medical treatment group, respectively (P  .728;
Figure 2).
Table 2 shows the results of univariate analysis of the
clinical and CT image variables. Only the wall thickness in
the CT images obtained 2 weeks after admission was found
to be significantly correlated with conversion to surgery,
and it was the only predictor of conversion of medical
treatment to surgery throughout the entire follow-up period
(P  .038). We calculated an optimal cutoff value of the
wall thickness at 2 weeks to predict progression to type A
aortic dissection within 4 weeks and found 12 mm to be an
optimal cutoff value, resulting in positive and negative
predictive values of 80% and 100%, respectively.
Discussion
IMH, the clinical presentation of which mimics that of acute
aortic dissection, is considered a unique pathologic entity
among aortic diseases. The process may arise from sponta-
neous rupture of the vasa vasorum12,13 or rupture of an
atherosclerotic plaque.5,14 The prevalence of IMH is re-
ported to be from 5% to 23%4,15-17 of patients with acute
aortic syndromes.
Diagnostic Criteria and Confirmation
The diagnosis of IMH is based on the evidence of wall
thickness without intimal flap or disruption, by excluding
aortic dissection and penetrating atherosclerotic ulcer. Fur-
thermore, wall thickness with atherosclerosis and aortic
dissection with thrombosed false lumen should be excluded.
Because the characteristic CT findings of IMH described
by Yamada and coworkers12,18 have received wide recog-
nition, we introduced them as one of our diagnostic criteria.
On the basis of Yamada and coworkers’ description12,18
alone, however, it is difficult to differentiate IMH from wall
thickness with atherosclerosis or aortic dissection with
thrombosed false lumen. Our second diagnostic criterion
included having symptoms similar to those of aortic dissec-
tion and a time limit of 24 hours from the onset of symp-
toms to the initial CT examination. Patients with wall thick-
ness with atherosclerosis usually have no symptoms.
Furthermore, in patients with aortic dissection with throm-
bosed false lumen, the false channel may be opacified on
contrast CT scan unless the thrombosing process occurred
very rapidly (within 24 hours). Thus we considered that
these criteria could exclude wall thickness with atheroscle-
rosis and aortic dissection with thrombosed false lumen in
all cases but those with very rapid thrombosis.
To obtain an accurate diagnosis of IMH, however, the
diagnosis must be confirmed by further examinations. Pa-
tients in the early surgery group had confirmation through
operative findings. Patients in the medical treatment group
had confirmation through serial CT findings, morphologic
changes in aortic wall thickness that differed from wall
thickness with atherosclerosis, and combined use of mag-
netic resonance imaging and digital subtraction angiography
negative for aortic dissection and penetrating atheromatous
ulcers (“giant ulcers”), as described in previous reports.4
Even though various invasive and noninvasive imaging
techniques, such as CT5,9,12 scan, magnetic resonance im-
aging18-20, transesophageal echocardiography,8,21 aortogra-
phy with digital subtraction angiography,22 and intravascu-
lar ultrasonographic imaging,11,23 have been used to
Figure 2. Cumulative survival curve by Kaplan-Meier method.
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diagnose IMH, we used CT scanning for the initial diagno-
sis. CT is a useful modality not only for detecting aortic wall
abnormalities and the location of aortic abnormalities but
also for evaluating the presence of pericardial and pleural
effusion or rupture into the mediastinum. These findings
provided important information on whether to choose sur-
gical or medical treatment. Furthermore, a high-speed four-
row detector CT system (Aquilion; Toshiba Corporation
Medical Systems Company, Tokyo, Japan) is now available
that can scan the entire aorta (from ascending to abdominal
aorta) within half a minute. In consideration of the thera-
peutic approach, CT scanning is the first choice of diagnos-
tic technique, especially in emergency situations.
Management of Type A IMH
According to previous reports,3-7,10,17,19,21 patients with type
B IMH can be treated the same as those with type B aortic
dissection.24 However, the optimal mode of management of
patients with type A IMH, for whom previous clinical data
are limited, remains controversial.
Some reports have noted that medical treatment alone
leads to a poor prognosis for patients with type A IMH.3-7
Yamada and coworkers18 reported 6 cases of type A IMH.
All 6 patients were treated medically, and 2 of them died
within 1 month. Neiaber and colleagues4 reported that in
their series of 12 patients with type A IMH, the 30-day
mortality was 80% with medical treatment, versus 0% with
early surgical repair (P  .01), and they concluded that
early surgical repair should be considered for all patients
with type A IMH. Similar results were described by Harris
and coworkers.17 Furthermore, Maraj and associates,7 in
their meta-analysis of 143 reported cases of IMH, found that
patients with type A IMH who underwent surgery had a
significantly better prognosis than did those who received
medical treatment (14% vs 36% mortality, respectively,
P .02). These reports noted the risk of progression of type
A IMH to overt dissection or aortic rupture and the limita-
tion of medical treatment alone in patients with type A IMH
in their explanation of why early surgical repair is recom-
mended.
On the other hand, considering the pathophysiologic
process in IMH, absence of flow and pressure communica-
tion with the aortic lumen may produce good results.8-11
Kaji and associates9 reported that in-hospital mortality was
5% in 22 cases of type A IMH, even though all of patients
were treated medically. Further, IMH of the ascending aorta
regressed in 12 patients (55%) and completely disappeared
in 6 of these 12 patients. Taking into account these findings,
the clinical course of type A IMH includes a whole spec-
trum of prognoses. In some cases immediate surgical repair
may be indispensable, whereas in other cases hematoma
within the aortic wall occasionally may be completely ab-
sorbed within a day or two.10,25
According to Movsowitz and colleagues’ proposal for
management of patients with penetrating atherosclerotic
ulcer, we carried out early surgery only for patients with
cardiac tamponade, impending rupture, or rupture. As a
result, in-hospital mortality in the medical treatment group
was 4%, and 1- and 2-year survivals were 92% and 81%,
respectively. These rates were not significantly different
from those in the early surgery group (11%, 89%, and 89%,
respectively). We therefore considered only patients with
type A IMH with cardiac tamponade, impending rupture, or
rupture to be candidates for early surgery.
However, it is well known that type A IMH progresses to
overt type A dissection with cardiac tamponade or aortic
rupture in some medically treated patients, and such pro-
gressions carry a poor prognosis. Previous studies have
shown that these progressions almost all occur within 7 days
from the onset of IMH.4 This period could be considered an
acute phase, like that of acute aortic dissection.24 The aortic
wall is extremely fragile, and consequently type A IMH
could easily progress to type A dissection with tamponade
or aortic rupture. We consider that resting in bed with
intensive antihypertensive therapy during this period could
help to prevent such serious events. In our study, no med-
TABLE 2. Results of univariate and multivariate analyses
Variable
Univariate Multivariate
2 P value Hazard ratio 95% Confidence interval P value
Age 2.718 .099
Sex 1.05 .204
Hypertension 0.851 .356
CT examinations on admission
Extent of IMH 0.102 .749
External diameter 2.914 .088
Wall thickness 0.023 .879
CT examinations 2 weeks later
External diameter 1.678 .195
Wall thickness 4.325 .038 1.127 1.007-1.262 .038
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ically treated patients with type A IMH had progression to
overt type A dissection or aortic rupture within 2 weeks
after the onset of IMH.
Although in 8 patients in the medical treatment group
IMH progressed to overt type A dissection, impending
rupture, or aortic dilatation during the follow-up period, all
of these patients received opportune surgery. In 7 of 8 cases
these progressions occurred within 3 months from the onset
of IMH. By not missing the opportunity to convert from
medical to surgical management, good long-term results
were obtained. For that purpose, close follow-up for at least
3 months with serial CT scans or other imaging modalities
is needed to evaluate the morphologic changes of IMH in
patients undergoing medical treatment.
Finally, it is important to clarify the predictive factors of
progression of IMH and conversion from medical treatment
to surgery. Kaji and associates9 reported on 23 patients with
type A IMH and concluded that the only significant predic-
tor of progression of IMH (although their definition of
progression was increasing maximum aortic wall thickness
in follow-up CT images or death from rupture) was maxi-
mum aortic diameter in initial CT images. They noted that
the optimal cutoff value was 50 mm. Nishigami and col-
leagues27 reported on 44 patients with type A or type B IMH
and mentioned that when overt aortic dissection occurred in
patients with IMH, in all cases IMH was still demonstrated
for longer than 1 month and the maximum aortic diameter
was more than 45 mm. Both studies pointed out that the
maximum aortic diameter in initial CT images might have
much to do with the progression of IMH. In our study, the
only significant predictor of conversion to surgery was the
wall thickness in CT images obtained 2 weeks after admis-
sion. Furthermore, we calculated an optimal cutoff value to
predict progression to type A IMH within 4 weeks. A cutoff
value of 12 mm in the wall thickness at 2 weeks was
obtained, resulting in positive and negative predictive val-
ues of 80% and 100%, respectively. This result suggests that
medically treated patients with a wall thickness at 2 weeks
less than 12 mm in diameter may not need to stay in hospital
for longer than 2 weeks. Also, elective operation should be
recommended for medically treated patients if wall thick-
ness is more than 12 mm in diameter at 2 weeks. The
number of our cases was as limited, however, as has been
the case in previous reports, and further study may be
needed.
There are a few limitations of this study. First, we
compared the results of medical group with those of the
surgical group and are lacking an appropriate control group.
Actually, medically treated patients were less ill patients.
We tried to discriminate the patients who should be treated
surgically from the patients who could be treated medically.
The next step would be to compare treatment strategies
between groups with similar clinical statuses. Second, a
4-week hospital stay is surely long. We found that wall
thickness at 2 weeks was the predictor of conversion to
surgery, and an optimal cutoff value of 12 mm was deter-
mined. As a result, hospital stay could be shortened.
Conclusion
Early surgical treatment is required for patients with type A
IMH combined with cardiac tamponade, impending rupture,
or rupture. Patients without tamponade, impending rupture,
or rupture may be candidates for medical treatment. How-
ever, serial imaging modalities, such as CT scan, magnetic
resonance imaging, and transesophageal echocardiography,
should be used, because in about 20% of cases IMH
progresses to overt type A dissection or progressive aortic
dilatation, and surgical repair is needed in such cases.
We thank Dr Shoko Komatsu for valuable help with statistical
analysis.
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